Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

Birtle, A J

Neuroendocrine differentiation in prostate cancer: is it detectable and treatable? [electronic resource] - BJU international Sep 2003 - 490 p. digital

Publication Type: Comment; Letter

1464-4096

10.1046/j.1464-410x.2003.t01-1-04376.x doi


Biomarkers, Tumor--blood
Chromogranin A
Chromogranins--blood
Humans
Male
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood